Stocks Jump To Close Out Volatile Week, And The Technical Take On The Market Swings 4/11/25

This episode explores the complexities of the current market volatility, focusing on the disconnect between stock and bond markets. Against the backdrop of a volatile week showing solid gains in the stock market (Nasdaq up 7%, S&P up 6%), a rapid rise in yields on the 10-year Treasury is causing concern. The panelists discuss various contributing factors, including record deficits, concerns from credit rating agencies, and the impact of tariffs on investor confidence. More significantly, the discussion highlights the unprecedented nature of this bond market rout, which is not Fed-induced, unlike previous crises. For instance, the panelists debate whether this reflects a shift in global confidence in U.S. investments or a simple unwinding of trades. As the discussion pivots to the banking sector, the panelists analyze the recent earnings reports, noting a wait-and-see approach from clients and the impact of uncertainty on future lending. Finally, the conversation touches upon the FDA's plan to phase out animal testing in drug development, highlighting the potential impact on related companies and the broader biotech industry. What this means for investors is a need for careful consideration of the various cross-currents affecting different sectors, with some panelists suggesting a wait-and-see approach before making significant investment decisions.